Current Issue : October-December Volume : 2026 Issue Number : 4 Articles : 5 Articles
Acanthamoeba keratitis (AK) and mycotic keratitis (MK) are severe infectious diseases of the cornea. A major challenge to treatment is the poor bioavailability of conventional eye drop formulations, resulting in significant loss of the therapeutic compound. The present study describes the preparation of self-nanoemulsifying drug delivery systems (SNEDDSs) utilizing 3D-molded inserts as a vehicle for the co-delivery of voriconazole (VOR) and diclofenac sodium (DIC). Characterization of the SNEDDS and the 3D-molded inserts involved analysis of droplet size, polydispersity index (PDI), and zeta potential (ZP), followed by an ex vivo transcorneal permeation. Careful optimization of the SNEDDS composition was fundamental for obtaining a nanoemulsion with a droplet size under 100 nm, a PDI below 0.35, and a variable ZP (ranging from −14.6 ± 0.1 to 16.3 ± 2.4 mV). These properties facilitated a marked improvement in voriconazole’s solubility and subsequent transcorneal permeability. The investigation of the inserts revealed that the in vitro drug release could be tailored for immediate release or extended release. Moreover, ex vivo permeation studies demonstrated that the inserts delivered voriconazole to the cornea at concentrations more than the minimum inhibitory concentration. This work successfully demonstrates the formulation of a patient-centric, personalized drug delivery platform for the treatment of AK and MK....
Microneedle systems represent a promising minimally invasive approach for transdermal drug delivery; however, their performance strongly depends on the composition and mechanical properties of the polymer matrix. The aim of this study was to select an optimal polymer composition for the fabrication of dissolving microneedle arrays produced by the mold casting method. The study focused on evaluating mechanical strength, dissolution behavior, and penetration efficiency of different polymer systems. Microneedle matrices were fabricated using polyvinylpyrrolidone (PVP K-30), methylcellulose, sodium alginate, and hyaluronic acid at various concentrations, alone and in combination. No active pharmaceutical ingredient (API) was incorporated; the study was performed using blank polymeric systems intended for subsequent drug loading. The microneedles were manufactured using 3D-printed and silicone molds. Their performance was evaluated by in vitro dissolution testing, pH measurement, penetration studies in gelatin gel and Parafilm M models, and mechanical compression testing. Monopolymer systems demonstrated either rapid dissolution with insufficient mechanical strength or improved strength at the expense of prolonged dissolution time. Combined polymer formulations showed superior structural uniformity and balanced performance. In particular, the system containing 5% PVP K-30 and 10% sodium alginate demonstrated the best overall characteristics, achieving high penetration efficiency (up to 96%), uniform dissolution (78%), and appropriate dissolution time (8.5 ± 0.5 min). Addition of hyaluronic acid further improved structural uniformity and handling properties. The results indicate that composite polymer matrices provide an optimal balance between mechanical stability, penetration ability, and dissolution rate. The formulation consisting of 5% PVP K-30 and 10% sodium alginate was identified as the most promising base for further development of drug-loaded dissolving microneedle systems....
Background: Lidocaine and prilocaine cream is a compounded topical anesthetic formulation comprising lidocaine and prilocaine. Upon application, the active ingredients are locally released and permeate into the subcutaneous tissue, exerting anesthetic effects by blocking ion channels involved in nerve impulse transmission. Variations in drug permeation may influence the onset time, anesthetic efficacy, and duration of action. Methods: This study investigates the in vitro properties of the innovator formulation Emla® and five generic formulations through in vitro bioequivalence studies and Q3 Characterization tests. Results: With the exception of TS, the generic formulations exhibited notable differences compared to the innovator product. Specifically, TB and TL demonstrated significantly higher in vitro release than Emla®, yet exhibited lower in vitro permeation rates. In contrast, TH and TT showed release rates comparable to Emla®, while their permeation rates were similarly reduced. Conclusions: These findings indicate that in vitro release rate does not directly predict in vitro permeation. Permeation behavior is significantly influenced by emulsion globule size, rheological characteristics (viscosity and elasticity), and pH, collectively underscoring the multifactorial nature of this phenomenon....
Gabapentin (GAB), an anticonvulsant, is commonly used in veterinary medicine to manage anxiety, pain, and epilepsy. Although it is widely used, achieving personalized dosing for small animals remains a significant challenge. Threedimensional printing (3DP), particularly semi-solid extrusion (SSE), has shown promise in producing individualized dosage forms efficiently and with precision. Despite its advantages, SSE is limited by the need to freshly prepare the ink for printing and the extended post-processing times required for curing or solidifying the printed objects. This study investigated for the first time the feasibility of reusing a formulation designed for veterinary patients. The chewable tablets in this study were made using an already available proprietary gelatin-based excipient base, CuraVet®. Two formulations with varying GAB concentrations were printed using the same syringe initially and then again after 14 days of refrigerated storage. The formulation that contained a lower concentration of GAB maintained printability and dosing precision without requiring adjustments to printer settings, enabling the production of chewable tablets in under 30 min with a minimal amount of active work required. In contrast, the higher concentration formulation exhibited crystal formation, indicating instability. This proof-of-concept study demonstrated the feasibility of using reusable gelatin-based inks for on-demand 3D printing of veterinary medicines, highlighting their potential for clinical adoption in veterinary practices and pharmacies, provided that stability is carefully characterized....
Emissivity is a parameter allowing the assessment of thermal/optical properties of active pharmaceutical ingredients (APIs). ε reflects radiative properties, changes with product aging, and correlates with surface characteristics. This study analyzed the thermal emissivity of commercial tablets—extended-release tablets with metformin hydrochloride (from two manufacturers: XR I and XR II), coated (Co) tablets with ibuprofen, and chewable (Ch) tablets with sodium aluminum dihydroxycarbonate—and compared unexpired vs. expired products. We used the ET 100 emissometer (Surface Optics Corporation, USA; IR range 1.5–21 μm) to measure directional–hemispherical reflectance (DHR) at 300 K, and on the basis of these values, directional thermal emissivity at 20° (DTE20) and 60° (DTE60) and hemispherical thermal emissivity (HTE) were calculated. Then, emissivity parameters were evaluated at 500 K, 800 K, and 1200 K. The DHR values at a 60° angle differed between unexpired and expired XR II tablets across all spectral bands and for XR I tablets, except in the 3.0–4.0 micron range. In turn, for DHR at 20°, high effect sizes were demonstrated between unexpired and expired Ch tablets for 1.5–2.0, 2.0–3.5, 4.0–5.0, and 5.0–10.5 microns. For the DHR at 60°, the high effect size between unexpired and expired Ch tablets was found at 1.5–2.0, 2.0–3.5, and 4.0–5.0 microns. At 300 K, XR I and XR II tablets showed comparable DTE20, DTE60, and HTE. The Ch tablets had higher DTE20 than XR I and XR II (0.968 vs. 0.954 and 0.958, respectively; p < 0.001) and Co tablets (0.968 vs. 0.930; p < 0.001). The Co tablets had the highest DTE60 mean values (0.941 vs. 0.926 for Ch, p < 0.001; 0.926 for XR I, p < 0.001; 0.932 for XR II, p = 0.001). The HTE value was the highest for Ch tablets (p < 0.001 vs. others). During thermal modeling of the emissivity parameters, all DTE20, DTE60, and HTE values decreased with temperature, reaching their lowest values at 1200 K. The largest relative decrease in HTE values (over 15%) between the standard measurement temperature of 300 K and the modeled temperature of 1200 K was found for Ch tablets. Tablets with different release profiles show distinct DTE20, DTE60, and HTE values, suggesting that emissivity may serve as a rapid, non-destructive screening tool that could support further pharmaceutical evaluation during storage. However, emissivity alone does not establish pharmaceutical quality, and the present findings should be interpreted as proof-of-concept rather than as validation of a stand-alone quality- control method....
Loading....